The CNPV program aims to reduce drug review times to 1-2 months, raising concerns about safety and regulatory scrutiny. Critics argue that accelerated timelines may lead to safety issues and strain ...

His institute’s covid contrarians seek to limit the government’s role in protecting Americans from disease. The Austin, Texas ...

Natera, Inc. , a global leader in cell-free DNA and precision medicine, today announced that its employees contributed more than 1,500 volunteer hours during the company's fourth annual Volunteer ...

Teva Pharmaceutical Industries Ltd. today unveiled Teva Rise, a global open innovation platform designed to harness the power of a variety of disruptive technologies including AI, industry 4.0 smart ...

The first of seven challenges for which Teva is seeking novel solutions revolves around human-predictive platforms for ...

Reviews and recommendations are unbiased and products are independently selected. Postmedia may earn an affiliate commission ...

Martin Kulldorff, chair of the Trump administration’s reconstituted CDC vaccine panel, made a shocking — and misleading — ...

It's trendy in some circles to replace drinking with consuming cannabis. But can it help people with a drinking problem cut ...

Jefferies London Healthcare Conference 2025 November 18, 2025 12:00 PM ESTCompany ParticipantsMatthew Gline - CEO ...

FDA fast track designation facilitates expedited development of DPTX3186, recognizing its potential to address serious unmet medical needs in gastric cancer treatment. DPTX3186 gains FDA fast track ...

Amanda Murphy, senior director at GlobalData shares how companies can ensure success amidst consolidation in the clinical ...

A doctor advising ... sleepaway camp? That’s how a 12-year-old diagnosed with lupus found himself laughing on a high-ropes course as fellow campers ho ...